Skip to main content

Animations

MJFF Publications

2791 - 2800 of 8801 Results
Title
Year
  • Year
  • 2025
  • 2023
  • 2023
  • 2023
  • 2022
  • 2020
  • 2025
  • 2018
  • 2014
  • 2017
  • Summary Details
    RESTRICTED
    Title: Assessing DNA methylation detection for primary human tissue using Nanopore sequencing
    Journal Name: Genome Research
    Publisher: Cold Spring Harbor Laboratory
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1101/gr.279159.124
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Cerebrospinal fluid biomarkers profile in scans without evidence of dopaminergic deficits (SWEDD)
    Journal Name: IBRO Neuroscience Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ibneur.2023.10.001
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Association of cardiovascular disease management drugs with Lewy body dementia: a case–control study
    Journal Name: Brain Communications
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/braincomms/fcad346
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Gut mucosal cells transfer α-synuclein to the vagus nerve
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1172/jci.insight.172192
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Neuroinflammation and Immune Changes in Prodromal Parkinson’s Disease and Other Synucleinopathies
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-223245
    Citation Count: 59
  • Summary Details
    OPEN
    Title: GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds
    Journal Name: Frontiers in Cell and Developmental Biology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fcell.2020.562522
    Citation Count: 11
  • Summary Details
    RESTRICTED
    Title: 0345 Life Course Sleep Duration Trajectories and Risk and Age at Onset of Parkinson’s Disease
    Journal Name: SLEEP
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1093/sleep/zsaf090.0345
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's Disease
    Journal Name: Frontiers in Neuroinformatics
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fninf.2018.00053
    Citation Count: 49
  • Summary Details
    OPEN
    Title: High-throughput neuroimaging-genetics computational infrastructure
    Journal Name: Frontiers in Neuroinformatics
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fninf.2014.00041
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Functional Brain Imaging Synthesis Based on Image Decomposition and Kernel Modeling: Application to Neurodegenerative Diseases
    Journal Name: Frontiers in Neuroinformatics
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fninf.2017.00065
    Citation Count: 19
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.